CWBR
Closed
Cohbar Inc
0.41
0.00 (0.00%)
Last Update: 23 Jan 2025 23:00:00
Yesterday: 0.41
Day's Range: 0.41 - 0.41
Send
sign up or login to leave a comment!
When Written:
1.79
CohBar Inc is a clinical stage biotechnology company that focuses on developing mitochondria-based therapeutics to treat various diseases associated with aging. The company was founded in 2007 and is headquartered in Menlo Park, California. CohBar's lead product candidate is CB4211, which is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company also has several other product candidates in preclinical development for the treatment of diseases such as cancer, Alzheimer's disease, and cardiovascular disease. CohBar's approach to drug development involves targeting the mitochondria, which are the energy-producing organelles within cells, to address the underlying causes of age-related diseases. The company's mission is to improve the health and well-being of people as they age.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








